Andrew D. Zelenetz, MD, PhD¹, Wojciech Jurczak, MD, PhD^2*, Vincent Ribrag, MD³, Kim M. Linton, MBChB, PhD^4*, Graham P. Collins, MBBS, MA, MRCP, FRCPath, DPhil⁵, Mark Bishton, PhD, MBChB⁶, Javier López Jiménez, MD, PhD^7*, Bhagirathbhai Dholaria, MBBS⁸, Andrea Mengarelli, MD^9*, Tycel J. Phillips, MD¹⁰, Nagendra Prasad Sungala, MBBS FRACP FRCPA¹¹, Henry Chan¹², Gerardo Musuraca, MD, PhD^13*, Oonagh Sheehy, MB BCh BAO, MRCP, FRCPath^14*, Junyi Yan^15*, Weiming Xu, MD, PhD^15*, Michel Azoulay, MD, MBA^16* and Pier Luigi Zinzani, MD, PhD¹⁷

¹Memorial Sloan Kettering Cancer Center, New York, NY
²Maria Sklodowska-Curie National Research Institute of Oncology, Krakow, Poland
³Gustave Roussy Cancer Campus, Villejuif, France
⁴The Christie NHS Foundation Trust and Manchester Cancer Research Centre, Manchester, United Kingdom
⁵Oxford University Hospitals NHS Foundation Trust, Churchill Hospital, Oxford, ENG, United Kingdom
⁶Nottingham University Hospitals, Nottingham, United Kingdom
⁷Hematology Service, Hospital Universitario Ramón y Cajal, Madrid, Spain
⁸Department of Medicine, Division of Hematology and Oncology, Vanderbilt University Medical Center, Nashville, TN
⁹Regina Elena National Cancer Institute, Rome, ITA
¹⁰Department of Internal Medicine, Division of Hematology and Oncology, University of Michigan, Ann Arbor, MI
¹¹Department of Haematology, Liverpool Hospital, Sydney, NSW, AUS
¹²North Shore Hospital, Auckland, New Zealand
¹³Istituto Scientifico Romagnolo Per Lo Studio e La Cura Dei Tumori, Meldola, Italy
¹⁴Belfast HSC Trust, Belfast, United Kingdom
¹⁵MEI Pharma, Inc., San Diego, CA
¹⁶Kyowa Kirin Co., Princeton, NJ
¹⁷Institute of Hematology “Seràgnoli” University of Bologna, Bologna, Italy

Preetesh Jain, MBBS, MD, DM, PhD¹, Chi Young Ok, MD², Ahmed Fetooh^3*, Rashmi Kanagal-Shamanna, MD⁴, Fatima Zahra Jelloul, MD^2*, Holly Hill^5*, Kristen Floyd^6*, Sanam Loghavi, MD², Zhuang Zuo, MD^7*, C. Cameron Yin, MD, PhD⁸, Mark Routbort, MD, PhD^9*, Guilin Tang, MD, PhD^2*, Sairah Ahmed, MD⁸, Luis Enrique Malpica Castillo, MD⁸, Asiya Siddiqui^3*, Wendy Chen^10*, Onyeka Oriabure^5*, Maria Badillo, MSN, RN, OCN, CCRP^5*, Raphael E Steiner, MD¹¹, Swaminathan P. Iyer, MD⁵, Hun Ju Lee, MD⁵, Rajyalakshmi Luthra, PhD^2*, Francisco Vega, MD, PhD², Christopher R. Flowers, MD¹¹, Jeffrey Medeiros, MD, PhD^2*, Michael L. Wang, MD¹², Keyur P. Patel, MBBS, PhD², Nathan H. Fowler, MD^8,13 and Ranjit Nair, MD¹⁴

¹Department of Lymphoma and Myeloma, UTMDACC, Houston, TX
²Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX
³The University of Texas MD Anderson Cancer Center, Houston
⁴Department of Hematopathology, The University of Texas M D Anderson Cancer Center, Houston, TX
⁵Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
⁶UT MD Anderson Cancer Center, Houston
⁷University of Texas, MD Anderson Cancer Center, Houston, TX
⁸The University of Texas MD Anderson Cancer Center, Houston, TX
⁹Department of Hematopathology, University of Texas MD Anderson Cancer Center, Houston, TX
¹⁰Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, NEW YORK, NY
¹¹Department of Lymphoma and Myeloma, MD Anderson Cancer Center, Houston, TX
¹²MD Anderson Cancer Center, Houston, TX
¹³BostonGene Corporation, Waltham, MA
¹⁴Department of Lymphoma/Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX

Sunandini Sharma^1*, Alyssa C. Bouska, Ph.D.^1*, Alicia Gamboa^2*, Roshia Ali, Ph.D^3*, Issa Ismail Issa^4*, Waseem G. Lone, Ph.D.^1*, Dylan T. Jochum, BS¹, Weiwei Zhang, Ph.D.^1*, Salma Elhag^5*, Dario Ghersi, PhD^6*, Dalia ElGamal, MSc, PhD⁷, Julie M. Vose, MD, MBA⁸, Chengfeng Bi, MD, PhD^3*, Akil Merchant, MD² and Javeed Iqbal, Ph.D.^1*

¹Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE
²Cedars-Sinai Medical Center, Los Angeles, CA
³University of Nebraska Medical Center, Omaha, NE
⁴Department of Clinical Medicine, Aalborg University, Aalborg, Denmark
⁵University of Nebraska Medical Center, Omaha
⁶University of Nebraska at Omaha, Omaha
⁷Eppley Institute for Research in Cancer, University of Nebraska Medical Center, Omaha, NE
⁸Division of Hematology & Oncology, Department of Internal Medicine, University of Nebraska Medical Center - Fred and Pamela Buffett Cancer Center, Omaha, NE

Angela Ferrari, MD^1*, Sara Rattotti^2*, Simone Ferrero, MD³, Michele Merli, MD^4*, Francesco Merli, MD^1*, Sara Veronica Usai^5*, Marina Deodato, MD^6*, Alessandro Pulsoni^7*, Emanuele Cencini, MD^8*, Francesca Re, MD^9*, Maria Chiara Tisi, MD^10*, Marcia Torresan Delamain, MD, PhD^11*, Michele Spina, MD¹², Ombretta Annibali, MD, PhD^13*, Angela Rago, MD^14*, Carola Boccomini^15*, Andrés J M Ferreri, MD¹⁶, Maria Elena Nizzoli, MD^17*, Luca Arcaini^18*, Stefano Luminari, MD¹⁹ and Marzia Varettoni, MD^2*

¹Hematology, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy
²Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
³Hematology 1 U, Department of Molecular Biotechnologies and Health Sciences, University of Torino, Torino, Italy/AOU “Città della Salute e della Scienza di Torino”, Torino, Italy
⁴Division of Hematology, University Hospital Ospedale di Circolo e Fondazione Macchi - ASST Sette Laghi, University of Insubria, Varese, Italy
⁵Hematology, Ospedale Oncologico Armando Businco, Cagliari, Italy
⁶ASST Grande Ospedale Metropolitano Niguarda, Niguarda Cancer Center, Department of Hematology, Milano, Italy
⁷Institute of Hematology, University La Sapienza and Hospital Umberto I, Roma, Italy
⁸Division of Hematology, Azienda Ospedaliera Universitaria Senese and University of Siena, Siena, Italy
⁹Hematology and CTMO, Azienda Ospedaliera-Universitaria di Parma, Parma, Italy
¹⁰Cell Therapy and Hematology, San Bortolo Hospital, Vicenza, Italy
¹¹Hematology and Hemotherapy Center, University of Campinas, Campinas, Brazil
¹²Division of Medical Oncology and Immune-related Tumors, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano (PN), Italy
¹³Unit of Hematology, Stem Cell Transplantation, University Campus Bio Medico, Rome, Italy
¹⁴UOSD Ematologia, ASL Roma 1, Rome, Italy
¹⁵Division of Hematology 2, AOU Città della Salute e della Scienza di Torino, Torino, Italy
¹⁶Lymphoma Unit, Dept of Onco-hematology, IRCCS San Raffaele Scientific Institute, Milano, Italy
¹⁷PhD Program in Clinical and Experimental Medicine, University of Modena and Reggio Emilia, Modena, Italy
¹⁸Department of Molecular Medicine, University of Pavia, Pavia, Italy
¹⁹Hematology Unit, Azienda USL-IRCCS di Reggio Emilia, REGGIO EMILIA, Italy

Paolo Strati, MD¹, Beth Christian², Peter Martin, FRCPC, MD, MS³, Becky Champion^4*, Morton Coleman, MD^5*, Richy Agajanian, MD^6*, Sonali M. Smith, MD⁷, Parameswaran Venugopal, MD⁸, Izidore S. Lossos, MD⁹, Robert Kridel, MD¹⁰, Roser Calvo^11*, Kara Higgins^12* and Deborah M. Stephens, DO¹³

¹The University of Texas MD Anderson Cancer Center, Houston, TX
²The Ohio State University Comprehensive Cancer Center, Columbus, OH
³Weill Cornell Medical College, New York Presbyterian Hospital, New York, NY
⁴Norton Cancer Institute, Louisville, KY
⁵Clinical Research Alliance/Weill Cornell Medicine, New York, NY
⁶The Oncology Institute of Hope & Innovation, Downey, CA
⁷The University of Chicago Medical Center, Chicago, IL
⁸Rush University Medical Center, Chicago, IL
⁹University of Miami - Miller School of Medicine, Miami, FL
¹⁰Princess Margaret Cancer Centre, Toronto, ON, Canada
¹¹AstraZeneca, Gaithersburg, MD
¹²AstraZeneca, South San Francisco, CA
¹³University of Utah Huntsman Cancer Institute, Salt Lake City, UT

Lu Zhang, MD^1*, Yujun Dong^2*, Hongling Peng^3*, Hao Li, MD^4*, Mingzhi Zhang, MD, PhD⁵, Hui-Han Wang^6*, Qinhua Liu^7*, Liping Su^8*, Liye Zhong^9*, Wenjun Wu^10*, Liang Huang, MD¹¹, Xiaojing Yan, MD, PhD¹², Lei Fan^13*, Wenjiao Tang, MD^14*, Zhenling Li^15*, Lintao Bi^16*, Yan Li^17*, Guangxun Gao, MD^18*, Li Gao^19*, Ting-Bo Liu^20*, Yongqiang Wei^21*, Yao Liu^22*, Yu Li^23*, Hui Zhou^24*, Chunyan Sun, MD^25*, Wenbin Qian, MD, PhD²⁶, Dehui Zou^27*, Huilai Zhang^28*, Kaiyang Ding^29*, Xiaobo Wang^30*, Ou Bai, MD/PhD^31*, Wenrong Huang^32*, Bing Chen^33*, Lin Yang^34*, Jia Song^35*, Da Gao^36*, Tong Chen, MD³⁷, Jun Luo^38*, Shuye Wang^39*, Liangming Ma, MD^40* and Jian Li, MD⁴¹

¹Department of Hematology, Chinese Academy of Medical Sciences & Peking Union Medical College, Peking Union Medical College Hospital, Beijing, China
²Department of Hematology, Peking University First Hospital, Beijing, China
³Department of Hematology, Second Xiang-ya Hospital, Central South University, Changsha, China
⁴Department of Hematology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China
⁵Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
⁶Department of Hematology, Sheng Jing Hospital of China Medical University, Shenyang, CHN
⁷Department of Hematology, the First Affiliated Hospital of Anhui Medical University, Hefei, China
⁸Department of Hematology, Shanxi Cancer Hospital, Taiyuan, China
⁹Department of Hematology, Guangdong Provincial People’s Hospital/Guangdong Academy of Medical Sciences, Guangzhou, China
¹⁰Bone Marrow Transplantation Center, The First Affiliated Hospital of Zhejiang Medical College, Zhejiang University, Hangzhou, China
¹¹Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
¹²Department of Hematology, First Hospital of China Medical University, Shenyang, China
¹³Department of Hematology, Jiangsu Province Hospital and Nanjing Medical University First Affiliated Hospital, Nanjing, China
¹⁴Department of Hematology, Institute of Hematology, West China Hospital Sichuan University, Chengdu, China
¹⁵Department of Hematology, China-Japan Friendship Hospital, Beijing, China
¹⁶Department of Hematology and Oncology, China-Japan Union Hospital of Jilin University, Changchun, China
¹⁷Department of Hematology, People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi, CHN
¹⁸Department of Hematology, Xijing Hospital, Xi'An, China
¹⁹Department of Hematology, Xinqiao Hospital, Army Medical University, Chongqing, China
²⁰Department of Hematology, Fujian Medical University Union Hospital, Fuzhou, CHN
²¹Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China
²²Department of Hematology, Chongqing Cancer Hospital, Chongqing, China
²³Department of Hematopathology, The Second Affiliated Hospital of Nanchang University, Nanchang, China
²⁴Department of Lymphoma & Hematology, Hunan Cancer Hospital/The Affiliated Tumor Hospital of Xiangya Medical School, Central South University, Changsha, China
²⁵Union Hospital,Tongji Medical College,Huazhong University of Science and Technology, Wuhan, China
²⁶Department of Hematology, The Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China
²⁷State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical Colleg, Tianjin, China
²⁸Department of Lymphoma, Tianjin Medical University Cancer Institute & Hospital, Tianjin, China
²⁹Department of Hematology, The First Affiliated Hospital of USTC, Hefei, CHN
³⁰Department of Hematology, The Second Hospital of Dalian Medical University, Dalian, CHN
³¹Department of Hematology, The First Hospital of Jilin University, Changchun, China
³²Department of Hematology, the Fifth Medical Center of Chinese PLA General Hospital, Beijing, China
³³Department of Hematology, Nanjing Drum Tower Hospital,the Affiliated Hospital of Nanjing University Medical School, Nanjing, China
³⁴Department of Hematology, Second Hospital of Hebei Medical University, Shijiazhuang, CHN
³⁵Department of Hematology, General Hospital of Tianjin Medical University, Tianjin, China
³⁶Department of Hematology, The Affiliated Hospital of Inner Mongolia Medical University, Hohhot, China
³⁷Department of Hematology, Huashan Hospital, Fudan University, Shanghai, China
³⁸Department of Hematology, The First Affiliated Hospital of Guangxi Medical University, Guangxi, China
³⁹Department of Hematology, The First Affiliated Hospital of Harbin Medical University, Harbin, China
⁴⁰Department of Hematology, Shanxi Bethune Hospital, Taiyuan, China
⁴¹Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China

Tine Bennedsen^1*, Mikkel Simonsen^2*, Peter de Nully Brown, MD, PhD^3*, Michael Roost Clausen, MD, PhD^4*, Andriette Dessau-Arp, MD^5*, Judit Jørgensen, MD, PhD^6*, Thomas S. Larsen, MD, PhD^7*, Christian Bjørn Poulsen, MD^8*, Lasse Hjort Jakobsen, MSc, PhD^1* and Tarec Christoffer Christoffer El-Galaly, MD, DSc⁹

¹Department of Hematology, Aalborg University Hospital, Aalborg, Denmark
²Department of Hematology, Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark
³Department of Haematology, Rigshospitalet, Copenhagen, Denmark
⁴Department of Haematology, Vejle Hospital, Vejle, Denmark
⁵Department of Haematology, South West Jutland Hospital, Esbjerg, Denmark
⁶Department of Hematology, Aarhus University Hospital, Aarhus, Denmark
⁷Department of Hematology, Odense University Hospital, Odense, Denmark
⁸Department of Haematology, Zealand University Hospital, Roskilde, Denmark
⁹Aalborg University Hospital, Aalborg, Denmark

Takashi Watanabe, MD, PhD^1,2*, Kensei Tobinai, MD¹, Ｍasashi Wakabayashi, MSc^3*, Dai Maruyama, MD, PhD¹, Kazuhito Yamamoto, MD, PhD⁴, Nobuko Kubota, MD, PhD^5*, Kazuyuki Shimada⁶, Kohsuke Asagoe, MD, PhD^7*, Motoko Yamaguchi, MD, PhD⁸, Kiyoshi Ando, MD, PhD⁹, Michinori Ogura, MD, PhD¹⁰, Junya Kuroda, MD, PhD¹¹, Youko Suehiro, MD, PhD^12*, Yoshihiro Matsuno, MD, PhD^13*, Kunihiro Tsukasaki, MD, PhD¹⁴ and Hirokazu Nagai, MD, PhD¹⁵

¹Department of Hematology, National Cancer Center Hospital, Tokyo, Japan
²Department of Personalized Control Science of Myeloid and Lymphoid Tumors, Mie University Graduate School of Medicine, Tsu, Japan
³JCOG Data Center/Operations Office, National Cancer Center, Tokyo, Japan
⁴Department of Hematology and Cell Therapy, Aichi Cancer Center, Nagoya, Japan
⁵Department of Hematology, Saitama Cancer Center, Saitama, Japan
⁶Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan
⁷Department of Hematology and Oncology, Shiga General Hospital, Moriyama, Japan
⁸Department of Hematology and Oncology, Mie University Graduate School of Medicine, Tsu, Japan
⁹Division of Hematology/Oncology, Department of Internal Medicine, Tokai University School of Medicine, Isehara, Japan
¹⁰Department of Hematology and Oncology, Japanese Red Cross Aichi Medical Center Nagoya Daini Hospital, Nagoya, Japan
¹¹Division of Hematology and Oncology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan
¹²Department of Hematology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan
¹³Department of Pathology, Hokkaido University Graduate School of Medicine, Sapporo, Japan
¹⁴Department of Hematology, International Medical Center, Saitama Medical University, Saitama, Japan
¹⁵Department of Hematology and Oncology Research, National Hospital Organization, Nagoya Medical Center, Nagoya, Japan

Mariana Bastos-Oreiro, MD, PhD^1*, Antonio Gutierrez, MD, PhD^2*, Almudena Cabero Martínez^3*, Javier López Jiménez, MD, PhD^4*, Paola Sandra Villafuerte Gutierrez, MD^5*, Ana Jimenez-Ubieto, MD, PhD^6*, Adolfo De La Fuente, MD^7*, Belén Navarro, MD^8*, Maria Stefania Infante, MD^9*, Raul Cordoba, MD, PhD¹⁰, Jaime Perez De Oteyza, MD, PhD¹¹, Sonia González de Villambrosia, MD^12*, Raquel Del Campo^13*, Daniel Garcia^14*, Antonio Salar, MD, PhD^15* and Juan-Manuel Sancho, MD, PhD^16*

¹Servicio de Hematología y Hemoterapia, Hospital Gral. Univ. Gregorio Marañón, Madrid, Madrid, Spain
²Hematology Department, Hospital Universitario Son Dureta, Palma, Spain
³Hematology Department, Hospital Universitario de Salamanca, Salamanca, Spain
⁴Hematology Service, Hospital Universitario Ramón y Cajal, Madrid, Spain
⁵Hematology and hemotherapy department, Hospital Universitario Príncipe de Asturias, Alcala De Henares, Spain
⁶Hematology Department, Hospital Universitario 12 de Octubre, Madrid, Spain
⁷MD Anderson Cancer Center, Madrid, ESP
⁸Hematology Department, Hospital Universitario Puerta de Hierro, Madrid, Spain
⁹Hematology Department, Hospital Universitario Infanta Leonor, Madrid, Spain
¹⁰Fundacion Jimenez Diaz University Hospital, Health Research Institute IIS-JDF, Madrid, Spain
¹¹Hospital Universitario Madrid Sanchinarro, Madrid, Spain
¹²Hospital Universitario Marqués de Valdecilla, Santander, Spain
¹³Hematology Department, Hospital Son Llàtzer, Palma, Spain
¹⁴Hematology Department, Hospital Sanitas La Zarzuela, Madrid, Spain
¹⁵Department of Hematology, Hospital del Mar, Barcelona, ., Spain
¹⁶Clinical Hematology Department, Hospital Germans Trias i Pujol, Badalona, Spain

Tove Wästerlid, MD, PhD^1,2*, Anna Warnqvist^3*, Caroline E. Weibull, MSc, PhD^4*, Björn E Wahlin, MD, PhD^5,6, P-O Andersson, MD, PhD^7*, Gunilla Enblad, MD, PhD^8,9*, Eva Kimby, MD, PhD¹⁰ and Karin Ekstroem Smedby, MD, PhD^11,12*

¹Department of Hematology, Karolinska University Hospital, Stockholm, Sweden
²Department of Medicine Solna, Division of Clinical Epidemiology, Karolinska Institutet, Stockholm, Sweden
³Biostatistics Division, Department of Environmental Medicine, Karolinska Institutet, Stockholm, SWE
⁴Division of Clinical Epidemiology, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden
⁵Karolinska Institutet, Department of Medicine, Huddinge, Stockholm, Sweden
⁶Dept of Hematology, Karolinska University Hospital, Solna, Sweden
⁷Department of Hematology, Borås Hospital, Gothenburg, Gothenburg, Sweden
⁸Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden
⁹Dept of Oncology, Akademiska University Hospital, Uppsala, Sweden
¹⁰Hematology, Karolinska Institute, Stockholm, Sweden
¹¹Department of Hematology, Karolinska University Hospital, Solna, Sweden
¹²Division of Clinical Epidemiology, Department of Medicine Solna, Karolinska Institutet, Stockholm, Stockholm, Sweden

Carla Hajj, MD^1*, Emily S. Lebow, MD^1*, Jisun Lee^1*, Beatrice Fregonese, MPH^2*, N. Ari Wijetunga, MD, PhD^3*, Harper Hubbeling, MD¹, Kathryn R. Tringale, MD, MAS^1*, Morgan E. Freret, MD, PhD^1*, Brandon S. Imber, MD¹ and Joachim Yahalom, MD¹

¹Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY
²Memorial Sloan Kettering Cancer Center, New York City, NY
³Radiation Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY

Jaimal Kothari^1*, Toby A. Eyre, MBChB, DipMedEd, MRCP, FRCPath, MD^1*, Ali Rismani^2*, Helen McCarthy, MBBS FRCP PhD FRCPath^3*, Angela Collins, MBBS^4*, David John Lewis, MBChB, PhD^5*, Suzanne O Arulogun, MBBS, FRACP, FRCPA⁶, William Wilson^7*, Laura Clifton-Hadley, BSc, PhD^8*, Darren Edwards^9*, Kushani Ediriwickrema^7*, Rebecca Auer, MRCP, FRPath, PhD^10*, Guy Pratt, MD FRCP FRCPath^11*, Ruth M. de Tute^12*, Roger G Owen^12* and Shirley D'Sa^13,14*

¹Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom
²University College London Hospital, UCLH Centre for Waldenström and Related Conditions, London, United Kingdom
³The Royal Bournemouth and Christchurch Hospitals NHS Foundation Trust, Bournemouth, United Kingdom
⁴Haematology, Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich, United Kingdom
⁵Department of Haematology, Derriford Hospital, Plymouth, United Kingdom
⁶University College London Hospitals NHS Foundation Trust, London, United Kingdom
⁷Cancer Research UK and UCL Cancer Trials Centre University College London, London, United Kingdom
⁸Cancer Research UK & UCL Cancer Trials Centre, University College London, London, United Kingdom
⁹Cancer Research UK Clinical Trials Unit, University College London Cancer Trials Centre, London, United Kingdom
¹⁰Bartholomew’s Hospital, Barts Health NHS Trust, London, United Kingdom
¹¹Queen Elizabeth Hospital Birmingham, WMRC, Birmingham, United Kingdom
¹²HMDS, Leeds Cancer Centre, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom
¹³Department of Haematology, University College London Hospital NHS Foundation Trust, London, United Kingdom
¹⁴Department of Haematology, University College London Hospitals NHS Foundation Trust, London, United Kingdom

Kamel Laribi, MD^1*, Stéphanie Poulain, MD, PhD^2*, Lise Willems, MD^3*, Fatiha Merabet, MD^4*, Charles Herbaux⁵, Damien Roos Weil, MD, PhD^6*, Alix Baugier de Materre, MD^7*, Xavier Roussel, MD^8*, Sabine Tricot, MD^9*, Jehan Dupuis, MD^10*, Ronan Le Calloch, MD^11*, Benoit Bareau, MD^12*, Marie C Béné, PharmSciD, PhD^13* and Veronique Leblond, MD, PhD¹⁴

¹Department of Hematogy, Centre Hospitalier Le Mans, Le Mans, France
²Service d'Hématologie Cellulaire, Centre de Biologie et Pathologie, CHRU de Lille, France/ INSERM UMR-S 1172, IRCL, Lille, FRA
³Cochin Hospital - Assistance Publique Hôpitaux de Paris, Paris, France
⁴Department of Hematology, CH Versailles, Le Chesnay, France
⁵Hematology Department, Montpellier University Hospital, Montpellier, France, Montpellier, France
⁶Hematology department, Sorbonne Université Hôpital Pitié Salpêtrière APHP, Paris, FRA
⁷CLINEA CRF Port Royal, Paris, France
⁸Centre Hospitalier Universitaire Besancon, Besancon, FRA
⁹Service d'Hématologie Clinique, CH de Valenciennes, Valenciennes, France
¹⁰Lymphoid Malignancies Department, Henri Mondor University Hospital, Créteil, France
¹¹Hematology Department, General Hospital, Quimper, France
¹²Service d'Hématologie et Médecine interne, Hôpital Privé Sévigné, Vivalto Santé, Cesson-Sévigné, France
¹³Biology Department, Nantes University Hospital, Nantes, France
¹⁴Sorbonne University, Hôpital Pitié Salpêtrière, Paris, France

Jonathan Moss^1*, Dirk Garmann^2*, Rupert Austin^1*, Florian Hiemeyer^2*, Matthew J. Matasar, MD, MS³, Pier Luigi Zinzani, MD, PhD^4,5, Vita Beckert^2*, Lidia Mongay Soler^6*, Barrett H. Childs⁶ and Peter N. Morcos^6*

¹Bast Inc Limited, Leicester, United Kingdom
²Bayer AG, Berlin, Germany
³Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
⁴Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale, Università di Bologna, Bologna, Italy
⁵Istituto di Ematologia “Seràgnoli”, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy
⁶Bayer HealthCare Pharmaceuticals, Inc., Whippany, NJ

Supriya Gupta, MD^1*, Christopher Graham, MD² and Philip A Haddad, MD³

¹Louisiana State University Health Sciences Centre, Shreveport, LA
²Louisiana State University Health Science Center-Shreveport, Shreveport, LA
³LSUHSC-S/Overton Brooks VAMC, Shreveport, LA

Alexey V Danilov, MD¹, Alexandra Muir, BSN, RN^2*, Ivana Melgar^3*, Sandrine Puverel, PhD^4*, Peter Sportelli, BS⁵, Hari P. Miskin, MSc⁶, Lu Chen, PhD^7* and Geoffrey Shouse, PhD, DO⁸

¹City of Hope, La Canada Flintridge, CA
²City of Hope National Medical Center, DUARTE, CA
³City of Hope, Duarte
⁴City of Hope, Duarte, CA
⁵TG Therapeutics, Inc., North Andover, MA
⁶TG Therapeutics, Inc., New York, NY
⁷Department of Information Sciences, City of Hope, Duarte
⁸Department of Hematology/HCT, City of Hope National Medical Center, Duarte, CA

Kurt S. Bantilan, MPH^1*, Kayleigh Rutherford, MS^2*, Joseph McCarter, PhD^2*, Noushin Farnoud, PhD^2*, Juan E. Arango-Ossa^3*, Elli Papaemmanuil, PhD⁴ and Andrew D. Zelenetz, MD, PhD⁵

¹Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY
²Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY
³Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY
⁴Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, NEW YORK, NY
⁵Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York

Antonio Pinto^1*, Emanuele Guardalben^2*, Marco Caltagirone^2*, Chiara Piparo^2*, Caterina Patti^3*, Elsa Pennese^4*, Sonya De Lorenzo^5*, Vincenzo Pavone^6*, Ugo Consoli^7*, Francesco Piazza, MD^8,9, Monia Capponi^10*, Benedetta Puccini, MD^11*, Luca Baldini, MD^12,13*, Alessandro Pulsoni^14*, Stefan Hohaus^15*, Piero Maria Stefani^16*, Simone Santini^17*, Vittorio Ruggero Zilioli, MD^18*, Caterina Stelitano^19*, Luca Arcaini, MD^20,21*, Giuseppe Gritti^22*, Marco Ladetto, MD^23,24 and Pier Luigi Zinzani, MD, PhD^25,26

¹Hematology-Oncology and Stem-Cell Transplantation Unit, Department of Hematology and Innovative Therapies, National Cancer Institute, Fondazione 'G. Pascale', IRCCS, 80131, Italy
²Roche S.p.A., Monza, Italy
³Division of Onco-Hematology, Azienda Villa Sofia Cervello, Palermo, Italy
⁴Lymphoma Unit, Department of Hematology, Ospedale Spirito Santo, Pescara, Italy
⁵Hematology and Bone Marrow Transplantation, A.O.R.N. “S. G. Moscati”, Avellino, ITA
⁶Hematology, "Card. G. Panico" Hospital, Tricase, Italy
⁷A.O.R.N. Garibaldi, Catania, Italy
⁸University of Padova, Padova, Italy
⁹Azienda Ospedaliera Universitaria di Padova, Padua, Italy
¹⁰Institute of Hematology, Ospedale S. Maria della Misericordia, University of Perugia, Perugia, Italy
¹¹Careggi University Hospital, Firenze, Italy
¹²University of Milan, Milan, Italy
¹³Hematology & BMT Unit, Fondazione IRCCS Ospedale Maggiore Policlinico di Milano, University of Milan, Milan, Italy
¹⁴Sapienza University of Rome, Rome, Italy
¹⁵University Policlinico Gemelli Foundation, IRCCS, Catholic University of the Sacred Heart, Roma, Italy
¹⁶Hematology Unit, General Hospital Ca' Foncello, Treviso, ITA
¹⁷ASL Toscana Centro, Prato, ITA
¹⁸Division of Hematology, ASST Grande Ospedale Metropolitano Niguarda, Milan, IT-MI, Italy
¹⁹Grande Ospedale Metropolitano, Reggio Calabria, RC, ITA
²⁰University of Pavia, Pavia, Italy
²¹Division of Hematology and Department of Molecular Medicine, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
²²Ospedale Papa Giovanni XXIII, Bergamo, ITA
²³Università del Piemonte Orientale, Alessandria, Italy
²⁴Azienda Ospedaliera SS Antonio e Biagio e Cesare Arrigo, Alessandria, ITA
²⁵IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia “Seragnoli”Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale Università di Bologna, Bologna, Italy
²⁶Institute of Hematology "Seràgnoli" University of Bologna, Bologna, Italy

Roxanna Seyedin, PhD^1*, Ken Hasegawa, PhD^2*, Krithika Rajagopalan, PhD^1* and Sally W Wade, MPH^3*

¹Anlitiks Inc., Dover, MA
²Kite, A Gilead Company, Santa Monica, CA
³Wade Outcomes Research and Consulting, Salt Lake City, UT

Kaitlin Annunzio, DO¹, Natalie S. Grover, MD², Rui Li, MPH^3*, Daniel Jones, MD, PhD⁴, Walter Hanel, MD^5*, Beth Christian⁴, Adam J. Olszewski, MD⁶ and Narendranath Epperla, MD, MS⁷

¹The Ohio State University, Columbus, OH
²Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC
³Division of Hematology, The Ohio State University, Columbus, OH
⁴The Ohio State University Comprehensive Cancer Center, Columbus, OH
⁵Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH
⁶Division of Hematology/Oncology, Brown University, Providence, RI
⁷The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Columbus, OH

Priyanka Gaitonde^1*, Ling Cai^2*, Paulo de Miranda, MD¹, Jack Roos^2*, Simon Rule^3* and Michael L. Wang, MD⁴

¹AstraZeneca, Gaithersburg, MD
²AstraZeneca, South San Francisco, CA
³AstraZeneca, Mississauga, ON, Canada
⁴MD Anderson Cancer Center, University of Texas, Houston, TX

Jose Angel Hernandez-Rivas, MD, PhD^1*, Pier Luigi Zinzani, MD, PhD², Mats Jerkeman, MD, PhD³, Malalatiana Be Harvel^4*, Suzy Van Sanden^5*, Joris Diels, MSc^5*, Asad Husain, BSc, MBA^6*, Christoph Tapprich, MD^7*, Sanjay Deshpande^8*, Steven Le Gouill, MD, PhD^9,10 and Martin Dreyling, MD¹¹

¹Department of Hematology, Hospital Universitario Infanta Leonor, Universidad Complutense, Madrid, Spain
²IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia “Seragnoli”Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale Università di Bologna, Bologna, Italy
³Skane University Hospital and Lund University, Lund, Skaane Laen, Sweden
⁴Janssen Health Economics & Market Access EMEA, High Wycombe, United Kingdom
⁵Janssen Health Economics & Market Access EMEA Statistics & Modelling, Beerse, Belgium
⁶Janssen Global Market Access, Toronto, Canada
⁷Janssen EMEA Medical Affairs, Neuss, Germany
⁸Janssen Global Medical Affairs, Raritan, NJ
⁹Institut Curie Comprehensive Cancer Center, Paris, France
¹⁰Hospitalier Universitaire de Nantes, Centre de Recherche en Cancérologie et Immunologie Nantes Angers, INSERM, Université de Nantes, Nantes, France
¹¹Klinikum der Universität München, LMU, Munich, Germany

Junyuan Qi^1*, Mingyuan Sun^1*, Dongmei Ji^2*, Ping Zhou^3*, Shuning Xing^3*, Cheng Huang^3*, Qiying Lu^3*, Wenzhi Tian^3* and Lugui Qiu⁴

¹State Key Laboratory of Experimental Hematology, National Clinical Research Center for Hematological Disorders, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China
²Department of Lymphoma, Fudan University Shanghai Cancer Center, Shanghai, China
³ImmuneOnco Biopharmaceuticals(Shanghai) Inc., Shanghai, China
⁴Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China

Jahanzaib Khwaja^1*, Simon Salter^2*, Aisha S Patel^3*, Robert Baker^2*, Rajeev Gupta^4*, Ali Rismani^5*, Charalampia Kyriakou⁵, Ashutosh D. Wechalekar, MD⁶, Josephine M.I. Vos^7,8* and Shirley D'Sa^1*

¹Department of Haematology, University College London Hospital NHS Foundation Trust, London, United Kingdom
²Health Services Laboratories, London, United Kingdom
³University College London Hospital, London, ENG, United Kingdom
⁴University College London Hospital, London, United Kingdom
⁵Department of Haematology, University College London Hospital, London, United Kingdom
⁶Department of Haematology, University College London Hospitals NHS Foundation Trust, London, United Kingdom
⁷Department of Hematology, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands
⁸Department of Immunohematology Diagnostics, Sanquin, Amsterdam, The Netherlands, Amsterdam, Netherlands

Mazyar Shadman, MD¹, Ian W. Flinn, MD PhD², Edwin C. Kingsley, MD³, Benjamin Freeman, MD^4*, Moshe Yair Levy, MD⁵, Houston Holmes, MD, MBA^5*, Charles M. Farber, MD PhD⁶, Arvind Chaudhry^7*, Rocco Crescenzo^8*, Adam Idoine^8*, Xiaoping Zhang, MD^8*, Aileen Cohen^8*, Kunthel By, MD^8*, Jane Huang, MD^8* and Jeff P. Sharman, MD⁹

¹University of Washington, Fred Hutchinson Cancer Research Center, Seattle, WA
²Sarah Cannon Research Institute/Tennessee Oncology, Nashville, TN
³Comprehensive Cancer Centers of Nevada, Las Vegas, NV
⁴Summit Medical Group, Florham Park, NJ
⁵Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas, TX
⁶Atlantic Hematology Oncology, Morristown Medical Center, Morristown, NJ
⁷Summit Cancer Centers, Spokane Valley, WA
⁸BeiGene (Beijing) Co., Ltd., Beijing, China and BeiGene USA, Inc., San Mateo, CA
⁹Willamette Valley Cancer Institute & Research Center, Eugene, OR

Sarah F. McGough^1*, Natasha Shamas^1*, Jue Wang^1*, Mahmoud Jaber^2*, Binay Swarup^2*, Marie-Helene Blanchet Zumofen^2*, Bertrand Lautié^2*, Joana Parreira^2*, Michael C. Wei¹ and Ashwini Shewade^1*

¹Genentech, Inc., South San Francisco, CA
²F. Hoffmann-La Roche Ltd, Basel, Switzerland

Vibeke Vergote^1*, Sylvia Snauwaert, MD, PhD^2*, Kirsten Saevels, MD³, Birgit De Beleyr^4*, Marjolein Lahaye^5*, Ariane Maes^4*, Hilde Demuynck^6*, Sarah Debussche^7* and Marc Andre, MD^8*

¹Department of Hematology, University Hospitals Leuven, Leuven, Belgium
²Department of Hematology, AZ Sint-Jan Brugge, Brugge, Belgium
³Division of Hematology, Antwerp University Hospital, Antwerp, Belgium
⁴Janssen-Cilag NV, Beerse, Belgium
⁵Janssen-Cilag BV, Breda, Netherlands
⁶Center for Human Genetics, Katholieke Universiteit Leuven, Leuven, Belgium
⁷Department of Onco-Hematology, AZ Maria Middelares, Gent, Belgium
⁸Department of Hematology, Université Catholique de Louvain, CHU UCL Namur, Yvoir, Belgium

Takayuki Ishikawa¹, Masahiro Takeuchi^2*, Kazuyuki Shimada³, Kohmei Kubo^4*, Takeshi Kondo⁵, Katsuya Fujimoto^6*, Tomoaki Fujisaki^7*, Koji Nagafuji⁸, Rika Sakai⁹, Shingo Kurahashi^10*, Tatsuro Jo^11*, Kazutaka Sunami¹², Senji Kasahara^13,14, Tomonori Nakazato¹⁵, Haiyi Guo^16*, William Novotny^16*, Chris Tankersley^16*, Motohisa Takai^16*, Hui Yao^16*, Jinhua Zhong^16*, Hongjie Zhu^16* and Koji Izutsu^17*

¹Kobe City Medical Center General Hospital, Hyogo, Japan
²Chiba Cancer Center, Chiba, Japan
³Nagoya University Hospital, Nagoya, Japan
⁴Aomori Prefectural Central Hospital, Aomori, Japan
⁵Aiiku Hospital, Sapporo, Japan
⁶National Hospital Organization Hokkaido Cancer Center, Sapporo, Japan
⁷Matsuyama Red Cross Hospital, Matsuyama, Japan
⁸Kurume University Hospital, Kurume, Japan
⁹Kanagawa Cancer Center, Yokohama, Japan
¹⁰Toyohashi Municipal Hospital, Toyohashi, Japan
¹¹Japanese Red Cross Nagasaki Genbaku Hospital, Nagasaki, Japan
¹²National Hospital Organization Okayama Medical Center, Okayama, Japan
¹³Gifu Pharmaceutical University, Gifu, Japan
¹⁴Gifu Municipal Hospital, Gifu, Japan
¹⁵Yokohama Municipal Citizen's Hospital, Yokohama, Japan
¹⁶BeiGene (Shanghai) Co., Ltd., Shanghai, China and BeiGene USA, Inc., San Mateo, CA
¹⁷National Cancer Center Hospital, Tokyo, Japan